CRISP Consortium Study Evaluates Elucid Bio’s vascuCAP AI Software to Predict Stroke
July 1, 2020—Elucid Bio, manufacturer of the vascuCAP software, announced that its artificial intelligence (AI) technology demonstrated > 70% improvement in the accuracy of stroke prediction compared with a stenosis-based approach to risk-stratification during a 6-year period in the CRISP Consortium study of carotid risk prediction.
SVS Issues Clinical Competence Statement on Training and Credentialing for TCAR
June 22, 2020—The Society for Vascular Surgery (SVS) announced the publication of a clinical competence statement on training and credentialing for transcarotid artery revascularization (TCAR) by Brajesh K. Lal, MD, et al online ahead of print in Journal of Vascular Surgery.
TCAR With Dynamic Flow Reversal Studied in Patients With Contralateral Carotid Artery Occlusion
June 19, 2020—Hanaa Dakour-Aridi, MD, et al published a study of the outcomes of transcarotid artery revascularization (TCAR) with dynamic flow reversal in patients with contralateral carotid artery occlusion (CCO).
Outcomes of Acute Carotid Stenting Studied in Patients With Tandem Lesions Undergoing Thrombectomy
June 12, 2020—A meta-analysis published by Gabrielle Dufort, et al in Journal of NeuroInterventional Surgery (JNIS) suggests that acute carotid stenting is associated with a greater likelihood of a favorable outcome at 90 days compared with no stenting in patients with tandem lesions (TL) undergoing endovascular thrombectomy (EVT).
InspireMD CGuard EPS Evaluated in Published 12-Month PARADIGM Results
June 10, 2020—InspireMD, Inc. announced that 12-month results from PARADIGM study of the company’s CGuard embolic prevention system for the prevention of stroke caused by carotid artery disease were published online by Adam Mazurek, MD, et al in EuroIntervention.
American College of Surgeons Releases Clinical Guidance for Elective Surgical Case Triage During COVID-19 Outbreak
March 25, 2020—The American College of Surgeons (ACS) announced continued guidance for surgeons to curtail recommendations for elective surgical procedures to preserve the necessary resources for care of critically ill patients during the COVID-19 pandemic.
Vascular Society of Great Britain and Ireland Provides Guidelines for Managing Treatment Amid COVID-19 Pandemic
March 20, 2020—Professor Chris Imray, MD, President of the Vascular Society of Great Britain and Ireland, announced guidelines from the society to address the rapidly evolving situation regarding the COVID-19 virus as it impacts patients and the particular challenges for health care workers.
Transradial Access for Neurointerventions Supported by Systematic Review of the Literature
March 9, 2020—A systematic literature review of the use of transradial access (TRA) for neurointerventional cases found that the TRA approach demonstrated a relatively low rate of access site complications and crossovers.
Study Reports on Use of Corindus’ CorPath GRX Robotic System for Neuroendovascular Procedures
March 1, 2020—Thomas Jefferson University in Philadelphia, Pennsylvania, announced that a study led by Pascal Jabbour, MD, Chief of the institution’s Division of Neurovascular Surgery and Endovascular Neurosurgery, demonstrated the safety and effectiveness of the CorPath GRX robotic-assisted surgical platform (Corindus Robotics Vascular, Inc.) to aid surgeons during diagnostic cerebral angiograms and transradial carotid artery stenting.
Role of Carotid Stents and Cerebral Protection on Cerebral Microembolization During CAS Evaluated
February 17, 2020—A study on the role of both carotid stent type and cerebral protection on cerebral microembolization during carotid artery stenting (CAS) was published by Piero Montorsi, MD, et al in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions (2020;13:403–414).
Vascular Medicine Consult Registry Launched for the SVS Vascular Quality Initiative
January 15, 2020—The Society for Vascular Surgery (SVS), the SVS Vascular Quality Initiative (VQI), and the American Heart Association (AHA) announced the introduction of the Vascular Medicine Consult (VMC) registry for the VQI—a collaboration of the SVS Patient Safety Organization (PSO), the Society for Vascular Medicine, and AHA.
Results Published From TCAR Surveillance Project
December 18, 2019—Silk Road Medical, Inc. announced that positive results from the ongoing TransCarotid Artery Revascularization (TCAR) Surveillance Project comparing TCAR and transfemoral carotid artery stenting (TF-CAS) have been published by Marc L. Schermerhorn, MD, et al in Journal of the American Medical Association (JAMA) (2019;322:2313–2322).
Data From the TCAR Surveillance Project Support Silk Road Medical's Enroute Devices
November 22, 2019—Silk Road Medical, Inc. announced the presentation of real-world data from the ongoing TransCarotid Artery Revascularization (TCAR) Surveillance Project at the VEITHsymposium held November 19–23 in New York, New York.
European Societies Publish Consensus Document on Follow-Up After Revascularization for PAD
November 14, 2019—A consensus document from European societies on the follow-up of patients after revascularization for peripheral artery disease (PAD) was published by Maarit Venermo, MD, et al in the European Journal of Vascular and Endovascular Surgery (2019;58:641–653).
Findings Published From Review and Analysis of RCTs Comparing CEA and CAS
September 26, 2019—Andrew J. Batchelder, MD, Athanasios Saratzis, MD, and A. Ross Naylor, MD, published findings of an overview of primary and secondary analyses from 20 randomized controlled trials (RCTs) comparing carotid artery stenting (CAS) with carotid endarterectomy (CEA). The study is published in European Journal of Vascular and Endovascular Surgery (EJVES; 2019;58:479–493).
Published Early Results From Matched Analysis Show Similar Risks for TCAR and CEA
July 23, 2019 – The Society for Vascular Surgery (SVS) announced the publication of the first report of a matched analysis of transcarotid artery revascularization (TCAR) and carotid endarterectomy (CEA), revealing a similar incidence of stroke and death at 30 days and 1 year.
ROADSTER-2 Demonstrates Positive Patient Outcomes With Silk Road's Enroute TCAR Systems
June 15, 2019—Silk Road Medical, Inc. announced positive final results for the company’s ROADSTER-2 postmarketing study evaluating real-world use of the Enroute neuroprotection and stent systems in transcarotid artery revascularization (TCAR) procedures.
Favorable Outcomes for TCAR Versus CEA Presented at Vascular Annual Meeting
June 13, 2019—Silk Road Medical, Inc. announced real-world data from the ongoing TransCarotid Artery Revascularization (TCAR) Surveillance Project evaluating the treatment of patients with carotid artery disease at risk for stroke.
Age-and-Outcomes Analysis of the VQI Supports TCAR in Elderly Patients
June 12, 2019—Hanaa Dakour-Aridi, MD, revealed findings from a study composed of patients in the Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) that compared the association between age and outcomes after transcarotid artery revascularization (TCAR), transfemoral carotid artery stenting (TFCAS), and carotid endarterectomy (CEA).
Sponsored by Medtronic
Sponsored by Silk Road Medical
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in Europe.